These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18509786)

  • 1. Pharmacological closure of patent ductus arteriosus: effects on pulse pressure and on endothelin-1 and vasopressin excretion.
    Zanardo V; Vedovato S; Chiozza L; Faggian D; Favaro F; Trevisanuto D
    Am J Perinatol; 2008 Jun; 25(6):353-8. PubMed ID: 18509786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic closure of the ductus arteriosus: benefits and limitations.
    Mercanti I; Boubred F; Simeoni U
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():14-20. PubMed ID: 19925358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary ET-1, AVP and sodium in premature infants treated with indomethacin and ibuprofen for patent ductus arteriosus.
    Zanardo V; Vedovato S; Lago P; Trevisanuto D; Favaro F; Faggian D; Plebani M
    Pediatr Nephrol; 2005 Nov; 20(11):1552-6. PubMed ID: 16133044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin-induced early patent ductus arteriosus closure cannot be predicted by a decrease in pulse pressure.
    Lubetzky R; Mandel D; Mimouni FB; Diamant S; Birger A; Barak M; Dollberg S
    Am J Perinatol; 2004 Jul; 21(5):257-61. PubMed ID: 15232757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibuprofen: alternative treatment for patent ductus arteriosus.
    Flores M
    Neonatal Netw; 2003; 22(2):27-31. PubMed ID: 12696723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report].
    Adamska E
    Med Wieku Rozwoj; 2000; 4(2 Suppl 3):65-71. PubMed ID: 11328971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.
    Cherif A; Jabnoun S; Khrouf N
    Am J Perinatol; 2007 Jun; 24(6):339-45. PubMed ID: 17564958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal anti-inflammatory drugs (NSAIDs) in the newborn - which ones?
    Aranda JV; Beharry KD; Valencia GB
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():21-2. PubMed ID: 19925359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of patent ductus arteriosus: indomethacin or ibuprofen?
    Sekar KC; Corff KE
    J Perinatol; 2008 May; 28 Suppl 1():S60-2. PubMed ID: 18446180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-steroid anti-inflammatory drugs in the treatment of patent ductus arteriosus in European newborns.
    Guimarães H; Rocha G; Tomé T; Anatolitou F; Sarafidis K; Fanos V
    J Matern Fetal Neonatal Med; 2009; 22 Suppl 3():77-80. PubMed ID: 19925365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and renal tolerability of ibuprofen vs. indomethacin in preterm infants with patent ductus arteriosus.
    Fanos V; Benini D; Verlato G; Errico G; Cuzzolin L
    Fundam Clin Pharmacol; 2005 Apr; 19(2):187-93. PubMed ID: 15810899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary aquaporin-2 excretion during ibuprofen or indomethacin treatment in preterm infants with patent ductus arteriosus.
    Li Y; Zelenina M; Plat-Willson G; Marcoux MO; Aperia A; Casper C
    Acta Paediatr; 2011 Jan; 100(1):59-66. PubMed ID: 21143292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High efficacy and minor renal effects of indomethacin treatment during individualized fluid intake in premature infants with patent ductus arteriosus.
    Leonhardt A; Strehl R; Barth H; Seyberth HW
    Acta Paediatr; 2004 Feb; 93(2):233-40. PubMed ID: 15046280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibuprofen lysine for the prevention and treatment of patent ductus arteriosus.
    Pai VB; Sakadjian A; Puthoff TD
    Pharmacotherapy; 2008 Sep; 28(9):1162-82. PubMed ID: 18752387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodevelopmental outcome after COX inhibitor treatment for patent ductus arteriosus.
    Rheinlaender C; Helfenstein D; Pees C; Walch E; Czernik C; Obladen M; Koehne P
    Early Hum Dev; 2010 Feb; 86(2):87-92. PubMed ID: 20153127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation for the use of oral ibuprofen and intravenous indomethacin in Korean infants with patent ductus.
    Heo MJ; Lee OS; Lim SC
    Arch Pharm Res; 2012 Sep; 35(9):1673-83. PubMed ID: 23054725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of prostaglandin production associated with reopening of the ductus arteriosus after indomethacin treatment in preterm infants with respiratory distress syndrome.
    Seyberth HW; Müller H; Wille L; Plückthun H; Wolf D; Ulmer HE
    Pediatr Pharmacol (New York); 1982; 2(2):127-41. PubMed ID: 12760405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
    Fakhraee SH; Badiee Z; Mojtahedzadeh S; Kazemian M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):399-403. PubMed ID: 17937843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.